# Efficacy of the Nanodropper Device on Pupillary Dilation

> **NCT05274321** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 50 (actual)

## Conditions studied

- Dilation

## Interventions

- **DEVICE:** Nanodropper
- **DEVICE:** Standard Eye Dropper

## Key facts

- **NCT ID:** NCT05274321
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-29
- **Primary completion:** 2021-11-19
- **Final completion:** 2021-11-19
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274321, "Efficacy of the Nanodropper Device on Pupillary Dilation". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05274321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*